Literature DB >> 24401601

Regulation of VASP by phosphorylation: consequences for cell migration.

Heike Döppler1, Peter Storz1.   

Abstract

Phosphorylations control all aspects of vasodilator-stimulated phospho-protein (VASP) function. Mapped phosphorylation sites include Y39, S157, S239, T278, and S322, and multiple kinases have been shown to mediate their phosphorylation. Recently, Protein Kinase D1 (PKD1) as a direct kinase for S157 and S322 joined this group. While S157 phosphorylation generally seems to serve as a signal for membrane localization, phosphorylations at S322 or at S239 and T278 have opposite effects on F-actin accumulation. In migrating cells, S322 phosphorylation increases filopodia numbers and length, while S239/T278 phosphorylations decrease these and also disrupt formation of focal adhesions. Therefore, the kinases mediating these phosphorylations can be seen as switches needed to facilitate cell motility.

Entities:  

Keywords:  VASP; cytoskeleton; filopodium; leading edge; migration; phosphorylation

Mesh:

Substances:

Year:  2013        PMID: 24401601      PMCID: PMC3916352          DOI: 10.4161/cam.27351

Source DB:  PubMed          Journal:  Cell Adh Migr        ISSN: 1933-6918            Impact factor:   3.405


  60 in total

Review 1.  Function and regulation of Ena/VASP proteins.

Authors:  Adam V Kwiatkowski; Frank B Gertler; Joseph J Loureiro
Journal:  Trends Cell Biol       Date:  2003-07       Impact factor: 20.808

2.  Loss of cell-cell contacts induces NF-kappaB via RhoA-mediated activation of protein kinase D1.

Authors:  Catherine F Cowell; Irene K Yan; Tim Eiseler; Amanda C Leightner; Heike Döppler; Peter Storz
Journal:  J Cell Biochem       Date:  2009-03-01       Impact factor: 4.429

3.  Vasodilator-stimulated phosphoprotein activation of serum-response element-dependent transcription occurs downstream of RhoA and is inhibited by cGMP-dependent protein kinase phosphorylation.

Authors:  Shunhui Zhuang; Giao T Nguyen; Yongchang Chen; Tanima Gudi; Martin Eigenthaler; Thomas Jarchau; Ulrich Walter; Gerry R Boss; Renate B Pilz
Journal:  J Biol Chem       Date:  2003-12-16       Impact factor: 5.157

4.  Lysophosphatidic acid (LPA)-induced vasodilator-stimulated phosphoprotein mediates lamellipodia formation to initiate motility in PC-3 prostate cancer cells.

Authors:  Yutaka Hasegawa; Mandi Murph; Shuangxing Yu; Gabor Tigyi; Gordon B Mills
Journal:  Mol Oncol       Date:  2008-06       Impact factor: 6.603

5.  Aberrant expression of human ortholog of mammalian enabled (hMena) in human colorectal carcinomas: implications for its role in tumor progression.

Authors:  Akihiro Toyoda; Hidetada Kawana; Kouji Azuhata; Jianyong Yu; Aya Omata; Hirohisa Kishi; Morihiro Higashi; Kenichi Harigaya
Journal:  Int J Oncol       Date:  2009-01       Impact factor: 5.650

6.  Vasodilator-stimulated phosphoprotein is a substrate for protein kinase C.

Authors:  K Chitaley; L Chen; A Galler; U Walter; G Daum; A W Clowes
Journal:  FEBS Lett       Date:  2004-01-02       Impact factor: 4.124

7.  Characterization of EVL-I as a protein kinase D substrate.

Authors:  Katrien Janssens; Line De Kimpe; Michele Balsamo; Sandy Vandoninck; Jackie R Vandenheede; Frank Gertler; Johan Van Lint
Journal:  Cell Signal       Date:  2008-10-29       Impact factor: 4.315

Review 8.  Role of Ena/VASP proteins in homeostasis and disease.

Authors:  G Pula; M Krause
Journal:  Handb Exp Pharmacol       Date:  2008

9.  A Mena invasion isoform potentiates EGF-induced carcinoma cell invasion and metastasis.

Authors:  Ulrike Philippar; Evanthia T Roussos; Matthew Oser; Hideki Yamaguchi; Hyung-Do Kim; Silvia Giampieri; Yarong Wang; Sumanta Goswami; Jeffrey B Wyckoff; Douglas A Lauffenburger; Erik Sahai; John S Condeelis; Frank B Gertler
Journal:  Dev Cell       Date:  2008-12       Impact factor: 12.270

Review 10.  Relaxing the actin cytoskeleton for adhesion and movement with Ena/VASP.

Authors:  Léa Trichet; Cécile Sykes; Julie Plastino
Journal:  J Cell Biol       Date:  2008-03-31       Impact factor: 10.539

View more
  22 in total

1.  Yersinia effector YopO uses actin as bait to phosphorylate proteins that regulate actin polymerization.

Authors:  Wei Lin Lee; Jonathan M Grimes; Robert C Robinson
Journal:  Nat Struct Mol Biol       Date:  2015-02-09       Impact factor: 15.369

2.  NKG2D-DAP10 signaling recruits EVL to the cytotoxic synapse to generate F-actin and promote NK cell cytotoxicity.

Authors:  Katelynn M Wilton; Brittany L Overlee; Daniel D Billadeau
Journal:  J Cell Sci       Date:  2019-07-18       Impact factor: 5.285

3.  Changes in Vasodilator-Stimulated Phosphoprotein Phosphorylation, Profilin-1, and Cofilin-1 in Accreta and Protection by DHA.

Authors:  Mehboob Ali; Lynette K Rogers; Kathryn M Heyob; Catalin S Buhimschi; Irina A Buhimschi
Journal:  Reprod Sci       Date:  2018-08-09       Impact factor: 3.060

4.  Vasodilator-stimulated phosphoprotein (VASP) regulates actin polymerization and contraction in airway smooth muscle by a vinculin-dependent mechanism.

Authors:  Yidi Wu; Susan J Gunst
Journal:  J Biol Chem       Date:  2015-03-10       Impact factor: 5.157

5.  Interleukin-17 augments tumor necrosis factor α-mediated increase of hypoxia-inducible factor-1α and inhibits vasodilator-stimulated phosphoprotein expression to reduce the adhesion of breast cancer cells.

Authors:  Kuang Changchun; Hu Pengchao; Su Ke; Wang Ying; Wei Lei
Journal:  Oncol Lett       Date:  2017-03-08       Impact factor: 2.967

6.  Granger-causal inference of the lamellipodial actin regulator hierarchy by live cell imaging without perturbation.

Authors:  Jungsik Noh; Tadamoto Isogai; Joseph Chi; Kushal Bhatt; Gaudenz Danuser
Journal:  Cell Syst       Date:  2022-06-07       Impact factor: 11.091

7.  Vasodilator-Stimulated Phosphoprotein (VASP) depletion from breast cancer MDA-MB-231 cells inhibits tumor spheroid invasion through downregulation of Migfilin, β-catenin and urokinase-plasminogen activator (uPA).

Authors:  Vasiliki Gkretsi; Andreas Stylianou; Triantafyllos Stylianopoulos
Journal:  Exp Cell Res       Date:  2017-02-14       Impact factor: 3.905

8.  Aortic disease in Marfan syndrome is caused by overactivation of sGC-PRKG signaling by NO.

Authors:  Andrea de la Fuente-Alonso; Marta Toral; Alvaro Alfayate; María Jesús Ruiz-Rodríguez; Elena Bonzón-Kulichenko; Gisela Teixido-Tura; Sara Martínez-Martínez; María José Méndez-Olivares; Dolores López-Maderuelo; Ileana González-Valdés; Eusebio Garcia-Izquierdo; Susana Mingo; Carlos E Martín; Laura Muiño-Mosquera; Julie De Backer; J Francisco Nistal; Alberto Forteza; Arturo Evangelista; Jesús Vázquez; Miguel R Campanero; Juan Miguel Redondo
Journal:  Nat Commun       Date:  2021-05-11       Impact factor: 14.919

9.  Thrombocytopenia-associated mutations in Ser/Thr kinase MASTL deregulate actin cytoskeletal dynamics in platelets.

Authors:  Begoña Hurtado; Marianna Trakala; Pilar Ximénez-Embún; Aicha El Bakkali; David Partida; Belén Sanz-Castillo; Mónica Álvarez-Fernández; María Maroto; Ruth Sánchez-Martínez; Lola Martínez; Javier Muñoz; Pablo García de Frutos; Marcos Malumbres
Journal:  J Clin Invest       Date:  2018-10-29       Impact factor: 14.808

10.  PP2A binds to the LIM domains of lipoma-preferred partner through its PR130/B″ subunit to regulate cell adhesion and migration.

Authors:  Veerle Janssens; Karen Zwaenepoel; Carine Rossé; Marleen M R Petit; Jozef Goris; Peter J Parker
Journal:  J Cell Sci       Date:  2016-03-04       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.